Haben orale Kontrazeptiva einen Stellenwert für die Prophylaxe und Therapie der Endometriose?

Trotz guter Erfahrungen in der klinischen Praxis gibt es aktuell auch Zweifel am Nutzen der Anwendung von kombinierten östrogenhaltigen Kontrazeptiva (KOK) bei Dysmenorrhö, wenn diese ein Symptom der Endometriose ist [1].

Publikationsverlauf

Artikel online veröffentlicht:
14. Juli 2020

• Literatur

• 1 Chapron C, Souza C, Borghese B. et al. Oral contraceptives and endometriosis: phe past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011; 26: 2028-2035
• 2 Koga K, Takamura M, Fujii T. et al. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril 2015; 104: 793-801
• 3 Vercellini P, Eskenazi B, Consonni D. et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 2011; 17: 159-170
• 4 Barbieri RL. Hormone treatment of endometriosis. The estrogen threshold hypothesis. Am J Obstet Gynecol 1992; 166: 740-745
• 5 Deb S, Campbell BK, Pincott-Allen C. et al. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2012; 39: 574-580
• 6 Dunselman GA, Vermeulen N, Becker C. et al. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29: 400-412
• 7 Brown J, Crawford TJ, Datta S. et al. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2018; (05) CD001019
• 8 Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017; 107: 533-536
• 9 Jenkins TR, Liu CY, White J. Does response to hormonal therapy predict presence or absence of endometriosis?. J Minim Invasive Gynecol 2008; 15: 82-86
• 10 Harada T, Momoeda M, Taketani Y. et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis. A placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583-1588
• 11 Tandoi I, Somigliana E, Riparini J. et al. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol 2011; 24: 376-379
• 12 Vercellini P, Somigliana E, Daguati R. et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008; 198: 504.e1-504.e5
• 13 Nezhat F, Nezhat C, Allan CJ. et al. Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med 1992; 37: 771-776
• 14 Herbel J. Untersuchungen zur Expression und endokrinen Regulation der epidermal growth factor receptor Familie in endometriotischen Läsionen [Dissertation]. Berlin: Charité – Universitätsmedizin Berlin; 2007